David R. Head

Benefit of cyclosporine modulation of drug resistance in patients with poor-risk acute myeloid leukemia: a Southwest Oncology Group study.

J. Doroshow, M. Slovak, F. Appelbaum, 2001, Blood.

Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia.

C. Bloomfield, E. Estey, W. Hiddemann, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study.

M. Slovak, F. Appelbaum, C. Willman, 2000, Blood.

N-ras mutations in adult de novo acute myelogenous leukemia: prevalence and clinical significance.

J. Radich, F. Appelbaum, C. Willman, 1990, Blood.

A phase I trial of combination fludarabine monophosphate and chlorambucil in chronic lymphocytic leukemia: a Southwest Oncology Group study.

M. Grever, F. Appelbaum, D. Head, 1993, Leukemia.

Treatment of acute lymphoblastic leukemia in adults with intensive induction, consolidation, and maintenance chemotherapy.

K., Weick, Head, 1989, Blood.

Mobilization of CD34+ progenitor cells by granulocyte colony-stimulating factor in human immunodeficiency virus type 1-infected adults.

D. Srivastava, D. Head, J. Garcia, 1996, Blood.